ETPrime

Rossari Biotech Share Price

  • 880.95-16.90 (-1.89%)
  • Volume: 98,812
  • Closed
  • Last Updated On: 30 Aug, 2024, 03:58 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Rossari Biotech Share P...

  • 880.95-16.90 (-1.89%)
  • Volume: 98,812
Advertisment

Rossari Biotech share price insights

View All

  • Company has spent 1.06% of its operating revenues towards interest expenses and 5.63% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

  • Company has used Rs 103.21 cr for investing activities which is an YoY decrease of 42.94%. (Source: Consolidated Financials)

  • Rossari Biotech Ltd. share price moved down by -1.89% from its previous close of Rs 897.85. Rossari Biotech Ltd. stock last traded price is 880.95

    Share PriceValue
    Today/Current/Last880.95
    Previous Day897.85897.45

InsightsRossari Biotech

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		35.69
    EPS - TTM
    (₹)    		24.68
    MCap
    (₹ Cr.)    		4,867.03
    Sectoral MCap Rank
    		29
    PB Ratio
    (x)    		4.73
    Div Yield
    (%)    		0.06
    Face Value
    (₹)    		2.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		890.26
    52W H/L
    (₹)
    966.00 / 656.95

    Rossari Biotech Share Price Returns

    1 Day-1.89%
    1 Week-3.52%
    1 Month6.74%
    3 Months27.23%
    1 Year6.92%
    3 Years-36.87%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Rossari Biotech belongs to analysts' top-rated companies list?

    View Stock Screeners

    Rossari Biotech News & Analysis

    View all Rossari Biotech Share News & Announcements

    Rossari Biotech Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Rossari Biotech Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 5 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Rossari Biotech recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy4443
    Buy1111
    Hold----
    Sell----
    Strong Sell----
    # Analysts5554
    View all Stock Recommendations

    Rossari Biotech Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.06% of its operating revenues towards interest expenses and 5.63% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income490.60473.11467.27484.83412.80
      Total Income Growth (%)3.701.25-3.6217.450.86
      Total Expenses440.14425.20415.19435.02366.97
      Total Expenses Growth (%)3.512.41-4.5618.54-0.25
      EBIT50.4647.9152.0849.8245.82
      EBIT Growth (%)5.33-8.024.558.7210.76
      Profit after Tax (PAT)34.9034.1334.3932.9529.22
      PAT Growth (%)2.25-0.754.3812.760.83
      EBIT Margin (%)10.2910.1311.1510.2811.10
      Net Profit Margin (%)7.117.217.366.807.08
      Basic EPS (₹)6.326.186.235.975.30
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income301.97315.15300.88333.98259.68
      Total Income Growth (%)-4.184.74-9.9128.61-2.36
      Total Expenses266.97278.66263.45295.93228.72
      Total Expenses Growth (%)-4.205.77-10.9729.39-2.50
      EBIT35.0036.4837.4338.0430.96
      EBIT Growth (%)-4.06-2.52-1.6222.87-1.37
      Profit after Tax (PAT)24.3326.1725.5426.3821.56
      PAT Growth (%)-7.032.45-3.1722.36-6.84
      EBIT Margin (%)11.5911.5812.4411.3911.92
      Net Profit Margin (%)8.068.308.497.908.30
      Basic EPS (₹)4.404.744.624.783.91
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1,838.001,661.371,494.97718.54603.82
      Total Revenue Growth (%)10.6311.13108.0619.0016.76
      Total Expenses1,660.561,518.101,360.24612.11515.76
      Total Expenses Growth (%)9.3811.61122.2218.6813.67
      Profit after Tax (PAT)130.69107.2697.6780.2265.25
      PAT Growth (%)21.859.8121.7622.9442.84
      Operating Profit Margin (%)10.759.999.9315.4215.26
      Net Profit Margin (%)7.136.476.5811.3010.87
      Basic EPS (₹)23.6719.4617.8115.5613.42
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue1,209.68978.771,085.54700.62603.73
      Total Revenue Growth (%)23.59-9.8454.9416.0516.74
      Total Expenses1,075.55883.13978.86594.63515.62
      Total Expenses Growth (%)21.79-9.7864.6215.3213.90
      Profit after Tax (PAT)99.6571.3979.4779.1065.52
      PAT Growth (%)39.58-10.170.4720.7344.13
      Operating Profit Margin (%)11.9510.2810.1815.7815.29
      Net Profit Margin (%)8.287.327.4011.4510.91
      Basic EPS (₹)18.0512.9514.4915.3413.48

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,572.151,367.571,256.72561.35471.52
      Total Assets Growth (%)14.968.82123.8819.0588.72
      Total Liabilities524.42452.40451.56152.58184.84
      Total Liabilities Growth (%)15.920.19195.96-17.4546.66
      Total Equity1,047.73915.17805.16408.77286.19
      Total Equity Growth (%)14.4913.6696.9742.83131.15
      Current Ratio (x)1.992.082.072.362.19
      Total Debt to Equity (x)0.100.080.010.000.21
      Contingent Liabilities0.0019.962.615.1321.23
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,281.171,125.67925.93544.36468.29
      Total Assets Growth (%)13.8121.5770.1016.2487.05
      Total Liabilities320.83266.97141.41139.92184.81
      Total Liabilities Growth (%)20.1788.791.06-24.2946.81
      Total Equity960.34858.70784.52404.44283.47
      Total Equity Growth (%)11.849.4693.9842.67127.72
      Current Ratio (x)2.012.052.632.442.17
      Total Debt to Equity (x)0.060.080.000.000.22
      Contingent Liabilities94.11125.56178.265.1321.23

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Cash from Operations vs PAT

        Operating cash flow of Rs 43.26 cr is 0.33 times compared to the reported net profit of Rs 130.69 cr. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 103.21 cr for investing activities which is an YoY decrease of 42.94%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities43.26152.3929.3647.7756.83
      Net Cash used in Investing Activities-103.21-180.89-298.88-37.18-190.30
      Net Cash flow from Financing Activities16.1960.86291.79-24.59156.94
      Net Cash Flow-44.0332.3622.27-14.0023.47
      Closing Cash & Cash Equivalent25.1769.8337.4815.2129.21
      Closing Cash & Cash Equivalent Growth (%)-63.9686.33146.43-47.94408.73
      Total Debt/ CFO (x)2.450.490.290.001.07
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities73.92113.6633.1252.0955.75
      Net Cash used in Investing Activities-69.55-160.59-318.12-37.00-187.25
      Net Cash flow from Financing Activities-22.0961.21296.91-29.45154.97
      Net Cash Flow-17.9514.2811.91-14.3623.46
      Closing Cash & Cash Equivalent22.5541.0226.7414.8329.19
      Closing Cash & Cash Equivalent Growth (%)-45.0453.4080.31-49.19539.88
      Total Debt/ CFO (x)0.740.570.000.001.09

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)12.4711.7112.1319.6222.80
      Return on Capital Employed (%)17.1516.2215.3126.6128.38
      Return on Assets (%)8.317.847.7714.2913.83
      Interest Coverage Ratio (x)13.2810.2415.4436.5725.76
      Asset Turnover Ratio (x)1.250.821.44126.36127.26
      Price to Earnings (x)28.5730.6751.5567.57-
      Price to Book (x)3.563.596.2513.18-
      EV/EBITDA (x)14.7814.1525.5140.08-
      EBITDA Margin (%)14.0513.7913.1718.6418.07
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)10.378.3110.1319.5523.11
      Return on Capital Employed (%)14.4111.1913.9026.8828.71
      Return on Assets (%)7.776.348.5814.5313.99
      Interest Coverage Ratio (x)17.3227.3453.2436.4324.96
      Asset Turnover Ratio (x)1.000.951.46126.83128.14
      Price to Earnings (x)37.4546.0863.2968.49-
      Price to Book (x)3.883.826.4113.32-
      EV/EBITDA (x)22.3525.8836.8640.46-
      EBITDA Margin (%)13.9612.9412.6218.9818.10

    Financial InsightsRossari Biotech

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 1.06% of its operating revenues towards interest expenses and 5.63% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Cash from Operations vs PAT

        Operating cash flow of Rs 43.26 cr is 0.33 times compared to the reported net profit of Rs 130.69 cr. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 103.21 cr for investing activities which is an YoY decrease of 42.94%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Rossari Biotech Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Rossari Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Rossari Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Rossari Biotech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Rossari Biotech Peer Comparison

    • Rossari Biotech Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Rossari Biotech35.694.6512.4717.158.3136.3310.757.1223.671.990.102.45
          Gujarat Fluorochem102.055.887.3210.814.7114.8717.0110.1639.601.360.343.19
          Clean Science & Tech63.2213.1920.2826.4817.4715.5041.3630.8322.974.120.000.00
          Jubilant Ingrevia60.153.826.689.293.8681.367.744.4211.561.380.271.70
          Galaxy Surfactants34.064.7813.8317.2110.3410.9610.487.9485.032.820.060.25
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Rain Ind.
          • NOCIL Ltd
          • Vidhi Specialty Food
          • Chembond Chem
          • Vikas Ecotech

          Choose from Stocks

            See All Parameters

          Peers InsightsRossari Biotech

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -32.31% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Rossari Biotech Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Rossari Biotech Shareholding as on 30 Jun 2024
            Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
            Promoters68.3268.3268.3368.35
            Pledge0.000.000.000.00
            FII3.834.024.145.73
            DII16.8117.7418.0617.68
            Mutual Funds12.9613.2713.9314.45
            Others11.049.929.468.24
          • Showing Shareholding as on 30 Jun 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters3,77,45,50068.32 %0.00
            Pledge00.00 %0.00
            FII21,15,8573.83 %-0.19
            DII92,85,44516.81 %-0.92
            MF71,60,32612.96 %-0.30
            Others61,00,66411.04 %1.11

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Rossari Biotech News Rossari Biotech Quarterly Results Rossari Biotech Dividend Rossari Biotech Q1 ResultsRossari Biotech Q2 ResultsRossari Biotech Q3 ResultsRossari Biotech Q4 Results

          Corporate Actions

          • Rossari Biotech Board Meeting/AGM

          • Rossari Biotech Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            Jul 20, 2024Jul 12, 2024Board MeetingQuarterly Results
            Apr 29, 2024Apr 22, 2024Board MeetingAudited Results & Final Dividend
            Jan 20, 2024Jan 12, 2024Board MeetingQuarterly Results
            Dec 08, 2023Nov 09, 2023POM-
            Oct 21, 2023Oct 13, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final25%0.5Aug 16, 2024Apr 29, 2024
            Final25%0.5May 24, 2023May 02, 2023
            Final25%0.5Jul 07, 2022May 20, 2022
            Final25%0.5Sep 08, 2021May 14, 2021

          • No other corporate actions details are available.

          About Rossari Biotech

          Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4,960.39 Crore) operating in Chemicals sector. Rossari Biotech Ltd. key Products/Revenue Segments include Organic/Inorganic Heavy Chemicals, Commission and Other Operating Revenue for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • EM

            Edward Menezes

            Executive Chairman
            SC

            Sunil Chari

            Managing Director
            AS

            Aparna Sharma

            Independent Director
            AD

            Aseem Dhru

            Independent Director
            Show More
          • Walker Chandiok & Co. LLP
            Deloitte Haskins & Sells LLP

          Industry

          Chemicals - Speciality - Others

          Key Indices Listed on

          BSE SmallCap, BSE Commodities, BSE AllCap, + 4 more

          Address

          201 A-B, 2nd Floor,Akruti Corporate Park,L.B.S. Marg, Next to GE Gardens,Mumbai, Maharashtra - 400078

          Contact

          [email protected]

          http://www.rossari.com

          More Details

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Rossari Biotech Share Price
          The Economic Times